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1) Is a policy of conventional surgical intervention more (cost) effective
than prolonged conservative care in patients with at least 3 months
intermittent neurogenic claudication due to lumbar spinal stenosis?
2) Is it possible to deﬁne subgroups of patients who will beneﬁt substan-
tially from one of the two proposed treatment strategies?
Methods: Population: Patients (n-280) presenting to the neurologist or neu-
rosurgeon in the participating hospitals with at least 3 months complaints
of intermittent neurogenic claudication and considering surgical treatment
are eligible for inclusion.
Inclusion criteria:
– age ≥50 years old
– ≥3 months intermittent neurogenic claudication, as noted by leg/buttock/
groin pain with or without back pain or fatigue in the legs provoked by
walking. Leg/buttock/groin pain or fatigue needs to be strongly relieved
when ﬂexed such as when sitting in a chair
– has a narrowed lumbar spinal canal, nerve root canal or intervertebral
foramen at one or more levels conﬁrmed by MRI.
Exclusion criteria:
– has a cauda equina syndrome deﬁned as neural compression causing
neurogenic bowel (rectal incontinence) or bladder dysfunction (bladder
retention or incontinence)
– has previously had a laminectomy at the same level, has degenerative or
lytic spondylolisthesis ≥ grade 2 (on a scale 1 to 4) at the affected level or
has signiﬁcant instability of the lumbar spine
Randomization: Allocation by means of a computer generated randomisation
list.
Measurements: Follow-up measurements will be completed during the
initial visit, during randomization and at 4, 12, 26, 38, 52, 104, 156, 208,
260 weeks after randomization.
Treatments:
1) Conventional surgical intervention. Participants allocated to direct
surgery will be operated as soon as possible and at the latest 4 weeks after
randomization. Surgical treatment will be performed in the conventional
manner with loupe magniﬁcation or microscope.
2) Prolonged conservative care. Conservative management will be a pro-
longed conservative treatment policy conducted by the general practitioner.
The general practitioner prescribes physical therapy which will consist of
active exercises to guide the patient in upgrading his or her activities
according to the agreed time schedule.
Primary outcomes:
– Zurich Claudication Questionnaire
– Shuttle walking test
Secondary outcomes:
– Neurological/clinical investigations
– Modiﬁed Roland Disabilty Questionnaire
– Visual analogue scale for Pain in back and leg
– Perceived Recovery
– Societal costs and utilities (EuroQol-5D, visual analogue scale)
– Complications
– Re-operation incidence
– Operative data
– Imaging ﬁndings
Analyses: Data analysis will be performed based on the intention to treat
principle. The answer to the main research question will be assessed with a
repeated-measures analysis of variance. For the cost-effectiveness analysis
a societal perspective will be taken, including health care costs, patient
costs and societal costs due to lumbar stenosis related disability (e.g.
inability to work and utilities expenses).
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Purpose: Tissue engineering is a possible method for long-term repair of
cartilage lesions, but current tissue engineered cartilage constructs have
inferior mechanical properties compared to native cartilage. We suggest
that the lack of an anisotropic, oriented microscale structure in the con-
structs that is present in the native tissue contributes to inferior mechanics.
This study tests the hypothesis that speciﬁcally-sized microscale channels
within collagen-based and polydimethylsiloxane (PDMS) substrates will
cause differentiating human mesenchymal stem cells (MSCs) to preferen-
tially orient themselves, and to create a microscale-oriented extracellular
matrix (ECM) similar to the native tissue.
Methods: Channels of varying microscale dimensions were formed in
collagen-chondroitin sulfate (Fig. 1) or PDMS membranes using micro-
fabrication and soft-lithography techniques. Collagen-based channels were
stabilized using carbodiimide crosslinking. The dimensional ﬁdelity of the
membranes was conﬁrmed by image analysis. Human MSCs were seeded
in these channels, and Live/Dead™ staining was used to assess MSC vi-
ability. Selective attachment of MSCs within the channels was ensured
by modifying the plateau regions of the membrane with Pluronic F108.
The chondrogenic potential of MSCs in the channels was investigated by
culturing them for 3 weeks in chondrogenic medium and evaluating them
using type II collagen immunohistochemistry. DiI was used to stain the cell
membrane and to evaluate whether stained collagen was extracellular. To
assess cell alignment within the channels, samples were stained for actin
(phalloidin) and cell nuclei (DAPI). ECM production and alignment were
evaluated using confocal imaging and cellular alignment was determined
by measuring the angle between the principal axis of cell nuclei and the
channel length.
Figure 1. Collagen-GAG membrane with channels.
Results: The channel widths were accurate relative to the template widths
used to produce the features in both PDMS and the collagen-based mem-
branes. The Pluronic F108 ensured selective cell attachment within the
channels (Fig. 2) and the MSCs remained highly viable. MSCs aligned along
the length of the smaller PDMS channels (25-100 μm), while random
spatial orientation was observed for larger channels (500-1000 μm, Fig. 3).
By confocal imaging, the type II collagen formed was extracellular and was
deposited in alignment with the cells (Fig. 4). Longer collagen ﬁbers are
seen farther from the cell indicating that assembly occurs.
Figure 2. PDMS membranes with (A) and without (B) Pluronic treatment.
Figure 3. Nuclear alignment angle ± SEM.
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Figure 4. Immunohistochemical staining after 14d in culture.
Conclusions: The microfabrication and collagen soft-lithography tech-
niques combined with crosslinking allowed high ﬁdelity formation of micro
sized channels on collagen membranes down to the smallest channel
designed (25 μm). The channels supported the viability of MSCs, while
selective cell attachment was ensured by the Pluronic treatment. Alignment
of MSCs along the length of the 25-100 μm channels and alignment of
collagen type II along the contours of the cell membrane within these
channels show the ability of these channels to inﬂuence cellular orientation,
which can lead to the alignment of ECM. To determine if the produced ECM
exhibits enhanced mechanical properties, mechanical testing comparing
oriented and random ECM produced in this system will be conducted in
future studies.
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Purpose: Although cell transplantation therapy using mesenchymal stem
cells (MSCs) is considered as a prominent strategy, one of the major prob-
lem is the limited proliferative activity. Recently, induced pluripotent stem
(iPS) cell line was developed as an alternative way due to their potential
proliferating inﬁnitely. However, the method to induce lineage-restricted
differentiation has not been well examined.
Methods: iPS cells were maintained on mouse embryonic ﬁbroblast feeder
layers. To induce mesenchymal cells, we used embryoid body (EB) forma-
tion followed by culture on gelatin-coated plates. We further introduced
micromass culture system to induce chondrocytes.
Results: The cultured adherent cells maintained multiple differentiation
properties to osteoblast, adipocyteand chondrocyte. (A) Alizarin red stain-
ing showed calcium deposition in osteoblast differentiation culture at day
10 of differentiation, and (B) oil red-O staining showed lipid accumulation
in adipocyte differentiation culture at day 10 of differentiation. (C) His-
tological and immunoﬂuorescent characterization of chondrocyte obtained
by pellet culture of the cultured adherent cells. They also possessed chon-
drogenic property, including Sox-9, aggrecan and type 2 collagen mRNA
expressions.
Conclusions: These results demonstrate the property of iPS cells as an
alternative candidate for treatment of cartilage degradation.
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Purpose: Osteoarthritis (OA) is one of the most frequent musculoskeletal
disorders and represents the main indication for total joint Arthroplasty.
Multipotent mesenchymal stromal cells (MSCs) can be easily isolated and
culture expanded from bone marrow aspirates and provide an excellent
source of progenitor cells. To assess whether advanced-stage OA affects
MSCs’ suitability for musculoskeletal regenerative therapy we compared
proliferation and differentiation potential as well as surface marker expres-
sion patterns of MSCs from osteoarthritic versus healthy donors.
Methods: MSCs were isolated from bone marrow aspirates (50 cc each)
obtained from the pelvic compartment of n=14 advanced-stage idiopathic
hip osteoarthritic (Kellgren and Lawrence grade 3 or 4, mean age 67±6
years) and n=15 age-matched (61±4 years) healthy donors by Ficoll
gradient-separation and plastic adherence. OA was objectiﬁed radiologi-
cally (only OA group) and by use of algofunctional indices (i.e. Western
Ontario McMaster Universities OA index, Harris Hip Score, EuroQol-5D).
MSCs were cultured in basic (DMEM, 10% fetal calf serum), osteogenic,
adipogenic, or chondrogenic medium for up to 21 days. For all assays
low-passage (<3) MSC populations were used. Proliferation was assessed
by total DNA quantiﬁcation, FACS analysis and CFU-F assay. Differentiation
was assessed immunocytologically, by cell-speciﬁc alkaline phosphatase
(ALP) activity assay, and by osteogenic (Runx-2, ALP, BSP2), chondrogenic
(Sox9, ColIIa, ColX), and adipogenic (PPARγ, FABP4) quantitative marker
gene real-time RT-PCR analysis. For expression analysis of selected MSC-
speciﬁc surface markers mean ﬂuorescence intensities and percentages of
positive cells were determined using a BD LSRII ﬂow cytometer. Overall
statistical signiﬁcance was deﬁned as p<0.05 (two-sided) based on all
pairwise comparisons. The study was approved by the local institutinal
review board (protocol #EK203082008).
Results: Algofunctional scores of osteoarthritic donors were lower com-
pared to healthy donors (p<0.0001). No signiﬁcant intergroup differences
were observed concerning the proliferation potential, cell-speciﬁc ALP
activity and adipogenic and osteogenic differentiation marker gene ex-
pression. Interestingly SOX9 gene expression levels were increased in
MSCs from OA patients after 14 day cultivation in chondrogenic medium
compared to MSCs from healthy donors (p<0.01). Expression levels of
CD73, CD90, and STRO-1 were elevated in respect of the negative control
cellular surface antigens CD14, CD34, and CD45 in MSCs derived from
both osteoarthritic and healthy donors (p<0.0001). Notable, MSCs from OA
patients showed decreased levels of CD166 expression compared to cells
from healthy donors (p<0.05).
Conclusions: The regenerative potential and surface marker patterns of
MSCs from osteoarthritic donors are comparable to MSCs from healthy
donors. However, the observed reduced CD166 expression levels as well
as the increased Sox9 gene expression levels in OA-MSCs warrants further
investigation. These data will help to facilitate the application of autologous
cell-based strategies for musculoskeletal tissue regeneration.
